.

Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Accenture
Johnson and Johnson
Express Scripts
Novartis
Baxter
Teva
Colorcon
Fish and Richardson
Daiichi Sankyo
Citi

Generated: November 24, 2017

DrugPatentWatch Database Preview

Drug Master Files for: clindamycin

« Back to Dashboard

DMF No. Status Type Submission Date Holder Subject
7193III10/26/1987DELMAR CHEMICALS INCCLINDAMYCIN PHOSPHATE
7289III1/5/1988AMERICAN CHEMICAL INDUSTRIAL CORPCLINDAMYCIN HYDROCHLORIDE
7359III2/29/1988AMERICAN CHEMICAL INDUSTRIAL CORPCLINDAMYCIN PHOSPHATE
12886III2/28/1998SUZHOU NUMBER 4 PHARMACEUTICAL FACTORYCLINDAMYCIN HYDROCHLORIDE ETHANOLATE INTERMEDIATE
12922AII4/2/1998TRIFARMA SPACLINDAMYCIN PHOSPHATE USP
12988AII5/15/1998SUZHOU NUMBER 4 PHARMACEUTICAL FACTORYCLINDAMYCIN ISOPROPYLIDENE, INTERMEDIATE
13082AII7/8/1998ZHEJIANG CANDORLY PHARMACEUTICAL CO LTDCLINDAMYCIN PHOSPHATE U.S.P.
13371III9/1/1998PFIZER INCCLINDAMYCIN HYDROCHLORIDE
13412AII9/1/1998PHARMACIA AND UPJOHN SUB PFIZER INCCLINDAMYCIN PALMITATE HYDROCHLORIDE USP KALAMAZOO
13413AII9/1/1998PHARMACIA AND UPJOHN CO LLC WHOLLY OWNED SUB OF PFIZER INCCLINDAMYCIN PHOSPHATE USP, KALAMAZOO
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.


Drug Master File Glossary

STATUS OF DMFS

  • A = Active. This means that the DMF was found acceptable for filing, administratively, and is up-to-date.
  • I = Inactive
  • N = Not an assigned number
  • P = DMF Pending Filing Review

TYPES OF DMFs

  • Type I Manufacturing Site, Facilities, Operating Procedures, and Personnel (no longer applicable)
  • Type II Drug Substance, Drug Substance Intermediate, and Material Used in Their Preparation, or Drug Product
  • Type III Packaging Material
  • Type IV Excipient, Colorant, Flavor, Essence, or Material Used in Their Preparation
  • Type V FDA Accepted Reference Information

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Dow
Cipla
Teva
Johnson and Johnson
Covington
Moodys
Baxter
Cantor Fitzgerald
Citi
US Department of Justice

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot